Hamilton finds the Key
February 12, 2014
Key Pharmaceuticals has
purchased skin and sun care
brand Hamilton from Valeant
International (PD breaking news)
and could have new products by
this time next year.
The move was described by
Key Pharmaceuticals ceo Clive
Addison as a significant step for
the company, extending its reach in
consumer products and markets.
He told PD he was proud that
an Aussie icon was coming to
the company as a privately held
business and the acquisition was a
“tremendous” opportunity for Key
Pharmaceuticals.
“The Hamilton range enhances
Key’s depth in the dermatology
category and extends our reach
in critical consumer products and
markets.”
The deal had been in the works
for several months, he said.
The company planned to develop
new consumer products with a
focus on skin and suncare.
Key Pharmaceuticals has a strong
pharmacy focus and was awarded
the Symbion 2013 ‘achieving
excellence award’ in the small to
medium OTC supplier category
demonstrating a level of confidence
in the company by the pharmacy
community.
The company will be speaking
to pharmacy customers about the
company’s plans in the next few
weeks and plans to speak with
them again around this time next
year about new products on offer.
“Hamilton is a strong addition to
our expansive portfolio of other
well-known brands including
Blistex, OsteVit-D, Tiger Balm, Ear
Clear and NeutraLice,” he added.
Distribution synergies between
Key and Hamilton will strengthen
both OTC ranges, a statement said.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Feb 14
